Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression

被引:10
作者
Wang, Maggie [1 ]
Peter, Samson S. [2 ]
Chu, Chi D. [3 ,4 ]
Tuot, Delphine S. [3 ,4 ,5 ]
Chen, Jonathan H. [6 ,7 ]
机构
[1] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Nephrol, Priscilla Chan & Mark Zuckerberg San Francisco Ge, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Ctr Innovat Access & Qual, San Francisco, CA 94143 USA
[6] Stanford Univ, Stanford Ctr Biomed Informat Res, 3180 Porter Dr,Room B132, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Med, Div Hosp Med, 3180 Porter Dr,Room B132, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
GLOMERULAR-FILTRATION-RATE; ALBUMINURIA; MORTALITY; FAILURE;
D O I
10.1001/jamanetworkopen.2022.25797
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Identification of patients with chronic kidney disease (CKD) with high risk of progression to kidney failure can help ensure they receive appropriate and effective nephrology care. OBJECTIVE To examine whether patients with CKD at various levels of kidney failure risk receive nephrology care within 1 year of established risk. DESIGN, SETTING, AND PARTICIPANTS This population-based, retrospective cohort study collected nationwide administrative health claims data from 156 733 adult patients who met the Kidney Disease: Improving Global Outcomes initiative CKD diagnostic criteria between January 1, 2012, and December 31, 2019, and had an available urine albumin to creatinine ratio within 90 days of a serum creatinine laboratory test. Patients with a history of dialysis or kidney transplant, a prior visit with a nephrologist in the past year, or palliative care billing codes or those who died or disenrolled within 1 year of the albumin to creatinine ratio measurement were excluded. Data analysis was performed from September 10, 2022, to February 14, 2022. EXPOSURES Kidney failure risk computed with the 5-year Kidney Failure Risk Equation. MAIN OUTCOMES AND MEASURES The main outcome was nephrology care rates across tiers of kidney failure risk, estimated as the proportion of individuals having a nephrologist visit within 1 year after index time. RESULTS The study population consisted of 156 733 patients with CKD (mean [SD] age, 74.6 [8.4] years; 91906 [58.6%] female; 86 457 [55.2%] White). A total of 106 004 patients (67.6%) had a low (<= 1%) 5-year risk of kidney failure. Nephrology visit rates increased with higher kidney failure risk. Among the 137 highest-risk patients, 79 (57.7%; 95% CI, 48.4%-64.7%) had a nephrology visit. Among 7730 patients with risk above a 10% threshold, 3208 (41.5%; 95% CI, 40.3%-42.4%) had a nephrology visit. CONCLUSIONS AND RELEVANCE This study's findings suggest that nearly half of patients with CKD at high risk of progressing to kidney failure do not have a nephrologist visit within 1 year of established risk. These findings have implications in the design of risk-based guidelines for referral and in the practice of delivering nephrology care to patients with CKD.
引用
收藏
页数:10
相关论文
共 50 条
[31]   Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study [J].
Dubin, Ruth F. ;
Whooley, Mary ;
Pico, Alexander ;
Genz, Peter ;
Schiller, Nelson B. ;
Meyer, Craig .
PLOS ONE, 2018, 13 (12)
[32]   High Prevalence of Unlabeled Chronic Kidney Disease Among Inpatients at a Tertiary-Care Hospital [J].
Ferris, Maria ;
Shoham, David A. ;
Pierre-Louis, Margareth ;
Mandhelker, Lawrence ;
Detwiler, Randal K. ;
Kshirsagar, Abhijit V. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (02) :93-97
[33]   THE EFFECT OF ARTERIAL STIFFNESS ON DISEASE PROGRESSION AND MORTALITY IN CHRONIC KIDNEY PATIENTS [J].
Erkus, Edip ;
Karakose, Suleyman ;
Kurtgoz, Pervin Ozkan ;
Gencer, Vedat ;
Guney, Ibrahim .
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2021, 84 (02) :214-220
[34]   Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort [J].
Titze, Stephanie ;
Schmid, Matthias ;
Koettgen, Anna ;
Busch, Martin ;
Floege, Juergen ;
Wanner, Christoph ;
Kronenberg, Florian ;
Eckardt, Kai-Uwe .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (03) :441-451
[35]   Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease [J].
Yun, Hae-Ryong ;
Joo, Young Su ;
Kim, Hyung Woo ;
Park, Jung Tak ;
Chang, Tae Ik ;
Son, Nak-Hoon ;
Yoo, Tae-Hyun ;
Kang, Shin-Wook ;
Sung, Suah ;
Lee, Kyu-Beck ;
Lee, Joongyub ;
Oh, Kook-Hwan ;
Han, Seung Hyeok .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (08) :1590-1601
[36]   Progressive chronic kidney disease in primary care: Modifiable risk factors and predictive model [J].
Herget-Rosenthal, Stefan ;
Dehnen, Dorothea ;
Kribben, Andreas ;
Quellmann, Thomas .
PREVENTIVE MEDICINE, 2013, 57 (04) :357-362
[37]   Kidney Stones and the Risk for Chronic Kidney Disease [J].
Rule, Andrew D. ;
Bergstralh, Eric J. ;
Melton, L. Joseph, III ;
Li, Xujian ;
Weaver, Amy L. ;
Lieske, John C. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (04) :804-811
[38]   Early Nephrology Referral for the Chronic Kidney Disease Patient: Seeing the Light or Groping in the Dark? [J].
Shavit, Linda ;
Slotki, Itzchak .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (08) :506-508
[39]   Body Mass Index and the Risk of Progression of Chronic Kidney Disease [J].
Khedr, Abdelrahman ;
Khedr, Essam ;
House, Andrew A. .
JOURNAL OF RENAL NUTRITION, 2011, 21 (06) :455-461
[40]   Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk [J].
Goicoechea, Marian ;
Garcia de Vinuesa, Soledad ;
Verdalles, Ursula ;
Ruiz-Caro, Caridad ;
Ampuero, Jara ;
Rincon, Abraham ;
Arroyo, David ;
Luno, Jose .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08) :1388-1393